This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NIH/NIAID LabKey Server Premium Enterprise License Renewal
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Health and Human Services, through the Office of Mission Acquisition Solutions on behalf of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, intends to renew a single annual Firm-Fixed-Price purchase order for the LabKey Server Premium Enterprise License, covering the period from August 29, 2026, to August 28, 2027. This renewal is essential to sustain the ongoing clinical research operations of the Division of Intramural Research and the Vaccine Research Center, as the LabKey platform is the established enterprise system for managing clinical samples, integrating research data, enabling secure collaboration, and ensuring regulatory compliance. The platform is deeply integrated into existing NIH systems and workflows, and replacing it would entail prohibitively high costs, substantial operational disruptions, and unacceptable risks to data integrity and research continuity. The Government has determined that renewal of the specified LabKey license is necessary to maintain compatibility, preserve existing data, and support uninterrupted access to mission-critical capabilities such as role-based security, audit trails, and system integrations. Market research has not identified an alternative solution that can meet these requirements without significant technical and procedural overhead. This action is being conducted under FAR Part 13 and FAR Part 12, allowing for a brand-name specification due to the unique and essential nature of the existing system. Interested vendors may submit capability statements demonstrating their ability to provide a fully compatible alternative, but the decision to proceed with or without the brand-name requirement rests solely with the Government. Responses must be submitted by July 31, 2026, to the designated contracting specialist, and no solicitation or quotation will be issued as this is solely a Notice of Intent.
General Info
Agency
Contract Value
$119,053NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Notice of Intent, not a request for quotation. No solicitation will be issued, and no quotations will be requested.
The Department of Health and Human Services (HHS), Office of Mission Acquisition Solutions (OMAS), on behalf of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), intends to award a firm-fixed-price purchase order for the renewal of the LabKey Server Premium Enterprise License.
Period of Performance: August 29, 2026 through August 28, 2027.
The purpose of this requirement is to renew the LabKey Server Premium Enterprise License that supports the National Institute of Allergy and Infectious Diseases (NIAID), Division of Intramural Research (DIR), and Vaccine Research Center (VRC). The LabKey platform serves as NIAID's enterprise data management solution for clinical research by supporting clinical sample management, study data integration, secure collaboration, and management of scientific research data.
The requirement includes the following:
- LabKey Server Premium Enterprise License Renewal
Quantity: One (1) Annual Enterprise License
- Premium Software Maintenance and Technical Support
Period of Performance: August 29, 2026 through August 28, 2027.
Justification for Brand Name
The Government requires renewal of the LabKey Server Premium Enterprise License to maintain continuity of operations and support ongoing clinical research activities within NIAID. The LabKey platform serves as the Institute's existing enterprise solution for managing clinical research data, laboratory sample information, and scientific collaboration. It is integrated with existing NIH research systems and established research workflows.
Renewal of the existing license is necessary to maintain compatibility with current system configurations, existing research data, established workflows, and system integrations. Replacing the current platform with an alternative product would require significant data migration, validation of migrated data, redevelopment of system integrations, reconfiguration of research workflows, user retraining, and additional implementation costs. Such efforts would introduce unnecessary technical, operational, and schedule risks while disrupting ongoing research activities.
The LabKey platform provides essential capabilities including secure role-based access controls, audit trails, regulatory compliance features, clinical sample management, and integration with existing NIH systems. Continued licensing ensures uninterrupted access to these capabilities while protecting the Government's investment in the existing enterprise solution.
Market research indicates that while other commercial research data management platforms exist, no alternative product has been identified that provides complete compatibility with NIAID's existing LabKey environment without substantial technical, operational, and programmatic impacts. Renewal of the existing LabKey Server Premium Enterprise License represents the solution that best satisfies the Government's minimum needs.
Authority
This acquisition is being conducted under Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures and FAR Part 12 – Acquisition of Commercial Products and Commercial Services. For purchases not exceeding the Simplified Acquisition Threshold, contracting officers may use simplified acquisition procedures and may include a brand-name specification when the Contracting Officer determines that the circumstances of the contract action make the brand-name item reasonably available and necessary to meet the Government's minimum needs. Contracts awarded using FAR Part 13 procedures are exempt from the requirements of FAR Part 6.
Submission of Capability Statements
Interested parties capable of providing the required LabKey Server Premium Enterprise License, or an equivalent solution, must submit a capability statement electronically. Responses will be considered solely for the purpose of determining whether to conduct a competitive procurement without the brand-name specification. A determination by the Government to proceed with the brand-name requirement, based upon responses to this notice, is solely within the discretion of the Government.
Capability statements must demonstrate the ability to provide a solution that fully satisfies the Government's requirements, including compatibility with the existing NIAID LabKey environment, preservation of existing research data and workflows, integration with current NIH research systems, secure role-based access, audit capabilities, regulatory compliance features, and uninterrupted support for ongoing clinical research operations.
Deadline: July 31, 2026, at 1:00 PM ET
Submit to:
Vera Nordalm
Contract Specialist
Office of Mission Acquisition Solutions (OMAS)
Email: vera.nordalm@hhs.gov
More opportunities from Department Of Health And Human Services → Omas Strategic Buying Center - Information Technology
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS